Ionis Pharmaceuticals (IONS) EBITDA Margin (QoQ) (2009 - 2026)

Ionis Pharmaceuticals (IONS) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ionis Pharmaceuticals 9.21 Bn 7.29 Bn 243.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5,776.00
Dec 31, 2025 -326.00
Sep 30, 2025 -709,301.00
Jun 30, 2025 710,239.00
Mar 31, 2025 -6,267.00
Dec 31, 2024 6,218.00
Sep 30, 2024 -8,175.00
Jun 30, 2024 9,578.00
Mar 31, 2024 -12,323.00
Dec 31, 2023 9,746.00
Sep 30, 2023 -5,148.00
Jun 30, 2023 3,958.00
Mar 31, 2023 4,950.00
Dec 31, 2022 -9,993.00
Sep 30, 2022 2,689.00
Jun 30, 2022 -2,340.00
Mar 31, 2022 -9,066.00
Dec 31, 2021 11,464.00
Sep 30, 2021 -648.00
Jun 30, 2021 2,438.00